Indian equities have surged in recent years driven by strong macro environment, corporate earnings, and domestic equity ...

Nifty Pharma index ended up 1.19% at 23582.25 today. The index has gained 2.00% over last one month. Among the constituents, Granules India Ltd rose 4.40%, Ipca Laboratories Ltd added 4.09% and ...

Sectoral performance was mixed. Nifty Pharma and Auto indices each rose by 2 percent, the Nifty IT index gained 1 percent, ...

The biggest losers on the BSE Sensex were TCS, M&M, ICICI Bank, Maruti, and Power Grid Corp. In contrast, the top gainers ...

At closing, Sensex was down 230 points, or 0.28 per cent, at 81,381 and Nifty was down 34 points, or 0.14 per cent, at 24,964 ...

The Nifty remained range-bound in the past week, with a minor weekly loss of 50.35 points (-0.20%). Volatility also tapered ...

This week, the Sensex fell 0.4 percent, and the Nifty 50 declined 0.2 percent. "The market has been facing selling pressure ...

For the second week running, broad market indices outshined their main counterparts, despite pressure on benchmark indices ...

Sumeet Bagadia, Executive Director at Choice Broking, has recommended State Bank of India (SBIN) to buy on the occasion of ...

On Friday, Indian equity markets concluded a volatile session with a downward trend, as the Sensex fell by 230.05 points or 0.28% to close at 81,381.36, and the Nifty declined by 34.20 points or 0.14% ...

Shares to buy or sell: The Indian market ended on a subdued note for the second consecutive session on Thursday, October 10, ...

FPIs have been investing in Chinese stocks which are cheap even now. However, “India has much better growth prospects now compared to China and, therefore, India deserves premium valuations”, said ...